MetLife (MET) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

MetLife

NYSE•Financial Services•Insurance - Life

$97.35+0.12(<0.01%)After hours

Market Cap

$62.33B

P/E

17.2x

P/S

0.8x

P/B

2.3x

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.

How this company scores

GoodMetricSide Score: 61/100

Strongest: Cash & Earnings Quality (21/25); weakest: Profitability (10/25).

Profitability10/25

Growth13/25

Balance Sheet & Red Flags17/25

Cash & Earnings Quality21/25

Strengths

Cash-backed earningsConsistent free cash flowConsistent growthNet cash position

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 17.2x5y range 8.0x – 30.9x

Currently near its 20-quarter median.

P/S · 0.8x5y range 0.6x – 0.8x

Currently near its 20-quarter median.

P/B · 2.3x5y range 0.8x – 2.3x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

Operating margins dropped 42.9% over recent quarters — a sharp decline suggesting serious cost or pricing challenges.

Price & Volume

Market Cap $62.33B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $79.40B
Q. Revenue: $19.15B
TTM EBITDA: $6.56B
TTM Op. Income: $6.56B
Q. Op. Income: $1.60B
TTM Net Income: $3.63B
Q. Net Income: $736.00M
EPS: $1.1
Shares Out.: $642.60M

$79.40B in TTM revenue grew 8.7% YoY, reaching $19.15B last quarter. TTM EBITDA of $6.56B and TTM operating income of $6.56B show growth is flowing through to the bottom line. TTM net income of $3.63B means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 3 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin: 8.4%
Op. Margin: 8.4%
Net Margin: 3.8%

Op. margin of 8.4% is up 0.3% YoY — cost efficiency is improving. Net margin at 3.8% Over the past year, operating margin is up 4% — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 17.2x
P/S Ratio: 0.8x
P/B Ratio: 2.3x

At 17.2x P/E, the stock trades within typical market levels. P/S of 0.8x and P/B of 2.3x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is up 37% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $759.37B
Cash: $19.30B
Long-Term Debt: $14.24B
Book Value: $27.44B
D/E Ratio: 0.5
Debt/EBITDA: 8.9

With $759.37B in assets and $14.24B in long-term debt, D/E is 0.5and book value is $27.44B — a conservative capital structure with a cushion to weather downturns. Over the past year, debt/equity is down 7% — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $2.23B
TTM Free Cash Flow: $15.56B
FCF Margin: 19.6%
FCF / Net Income: 4.3

TTM FCF of $15.56B on $2.23B in operating cash flow. The FCF / Net Income ratio of 4.3x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is up 2% — an improving trend.